Barbara Gladders
Overview
Explore the profile of Barbara Gladders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gilstrap L, Cohen A, Ouellet G, Goyal P, Gladders B, Flint D, et al.
J Am Geriatr Soc
. 2022 Oct;
71(2):404-413.
PMID: 36240493
Background: Contemporary patients with heart failure with reduced ejection fraction (HFrEF) are older and have a higher prevalence of cognitive impairment than those studied in trials. The risk/benefit trade-off of...
12.
Gilstrap L, Austin A, Gladders B, Goyal P, OMalley J, Barnato A, et al.
J Am Geriatr Soc
. 2021 Oct;
70(1):306-307.
PMID: 34626425
No abstract available.
13.
Gilstrap L, Austin A, Gladders B, Goyal P, OMalley A, Barnato A, et al.
J Am Geriatr Soc
. 2021 Jun;
69(10):2811-2820.
PMID: 34129234
Background/objectives: Neurohormonal therapy, which includes beta-blockers and angiotensin-converting enzyme inhibitor/angiotensin receptor blockers (ACEi/ARBs), is the cornerstone of heart failure with reduced ejection fraction (HFrEF) treatment. While neurohormonal therapies have demonstrated...
14.
Gilstrap L, Austin A, OMalley A, Gladders B, Barnato A, Tosteson A, et al.
J Gen Intern Med
. 2021 Jun;
36(8):2361-2369.
PMID: 34100232
Background: The demographics of heart failure are changing. The rate of growth of the "older" heart failure population, specifically those ≥ 75, has outpaced that of any other age group....
15.
Trooboff S, Wanken Z, Gladders B, Columbo J, Lurie J, Goodney P
Circ Cardiovasc Qual Outcomes
. 2020 May;
13(5):e006249.
PMID: 32375504
Background: Endovascular repair (EVR) has replaced open surgery as the procedure of choice for patients requiring elective abdominal aortic aneurysm (AAA) repair. Long-term outcomes of the 2 approaches are similar,...
16.
Wanken Z, Trooboff S, Gladders B, Columbo J, Ramkumar N, Austin A, et al.
Circulation
. 2020 Mar;
141(10):866-868.
PMID: 32150470
No abstract available.
17.
Gilstrap L, Skinner J, Gladders B, OMalley A, Barnato A, Tosteson A, et al.
Circ Cardiovasc Qual Outcomes
. 2020 Mar;
13(3):e006180.
PMID: 32148101
Background: To combat the high cost and increasing burden of quality reporting, the Medicare Payment Advisory (MedPAC) has recommended using claims data wherever possible to measure clinical quality. In this...
18.
Herndon M, Gladders B, Welch G, Mehta S, Belnap T, Morden N
J Gen Intern Med
. 2019 Dec;
35(2):599-602.
PMID: 31792858
No abstract available.
19.
Trooboff S, Wanken Z, Gladders B, Lucas B, Moore K, Barnes J, et al.
Ann Vasc Surg
. 2019 Oct;
62:148-158.
PMID: 31610277
Background: Endovascular aortic aneurysm repair (EVR) has a major financial impact on health care systems. We characterized reimbursement for index EVR hospitalizations among Medicare beneficiaries having surgery at Vascular Quality...
20.
Philpot L, Swanson K, Inselman J, Schoellkopf W, Naessens J, Borah B, et al.
Health Serv Res
. 2018 Nov;
54(1):117-127.
PMID: 30394529
Objectives: To evaluate the ability of claims-based risk adjustment and incremental components of clinical data to identify 90-day episode costs among lower extremity joint replacement (LEJR) patients according to the...